DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Sandostatin (Octreotide Acetate) - Current Clinical Trials


Sandostatin Related Clinical Trials

Study to Evaluate the Efficacy and Safety of Sandostatin LAR at High Dose or in Combination Either With GH-receptor Antagonist or Dopamine-agonist in Acromegalic Patients [Completed]

Ultrasound Guided Sandostatin LAR Injection in Acromegaly [Recruiting]

Combination of Bevacizumab, Pertuzumab, and Sandostatin for Adv. Neuroendocrine Cancers [Active, not recruiting]

Sandostatin in the Prevention of Postoperative Complications After Pancreaticoduodenectomy [Active, not recruiting]

Effects of Sandostatin LAR« in Acromegaly [Active, not recruiting]

Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis [Completed]

Efficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With Cirrhosis [Completed]

RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma [Completed]

Study Comparing SOM230 Subcutaneously and Sandostatin Subcutaneously in Acromegalic Patients [Completed]

Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor [Completed]

Evaluation of Octreotide LAR in Prevention of Chemotherapy-induced Diarrhea [Completed]

Efficacy and Safety Study of Octreotide Implant in Patients With Acromegaly [Terminated]

Efficacy/Safety of Octreotide Acetate in Patients With Uncontrolled Acromegaly [Completed]

Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anaemia Due to Small Bowel Angiodysplasias [Not yet recruiting]

Octreotide Therapy in Children and Young Adults With Prader-Willi Syndrome (PWS) [Terminated]

P:II Above-Label Octreotide-LAR With Insufficiently Controlled Carcinoid Syndrome [Terminated]

Preoperative Octreotide Treatment of Acromegaly [Completed]

A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours [Recruiting]

AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors [Completed]

Effects of Intraarterial Octreotide on Pancreatic Texture [Completed]

Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel [Terminated]

Phase II Study of Subcutaneous Injection Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs) [Recruiting]

Trial of Thalidomide, a- Interferon +/- Octreotide in Patients With Unresectable Hepatocellular Carcinoma [Completed]

Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma [Active, not recruiting]

Sandostatine« LP and Hyperinsulinism [Completed]

Long-term Safety and Efficacy Study of Octreotide Implant in Patients With Acromegaly [Terminated]

Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly [Active, not recruiting]

The Safety & Efficacy of Terlipressin vs Octreotide for the Control of Variceal Bleed [Completed]

High Dose Somatostatin Analogues in Neuroendocrine Tumors [Completed]

Pegvisomant And Sandostatin LAR Combination Study [Completed]

Ghrelin Suppression by Octreotide in Prader-Willi [Completed]

Octreotide LAR as Maintenance Treatment for Patients With NEC [Not yet recruiting]

Sandostatin LAR and Axitinib vs Pbo in Pnts With Advanced Well-differentiated Non-pancreatic Neuroendocrine Carcinomas [Active, not recruiting]

Sandostatin for Patients With Androgen Independent Prostate Cancer [Terminated]

Open Label Study of a Single Dose of a New Extended Long Acting Formulation of Octreotide Pamoate in Healthy Volunteers [Completed]

Efficacy and Safety of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease [Completed]

Octreotide in Severe Polycystic Liver Disease [Completed]

A Study of MK-0893 on Glucagon-Induced Glycemic Excursion in Healthy Male Participants Following Intravenous Administration of Glucagon, Sandostatine´┐Ż and Insulin (MK-0893-002) [Completed]

Everolimus and LongActing Octreotide Trial in Polycystic Livers [Completed]

5FU and Octreotide Long-acting Release (LAR) for Neuroendocrine Tumors [Completed]

Effects of Terlipressin When Usual Somatostatin or Octreotide Dose Fails [Recruiting]

Hemodynamic Effects of Terlipressin and High Dose Octreotide [Recruiting]

Octreotide Efficacy and Safety in First-line Acromegalic Patients [Suspended]

Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer [Completed]

Somatostatin Analog Treatment of Acromegaly Before Pituitary Surgery : Comparison With Neurosurgery Alone [Completed]

Prophylactic Octreotide to Prevent Post Duodenal EMR and Ampullectomy Bleeding [Recruiting]

Activity and Safety of Everolimus+Octreotide LAR+Metformin in Advanced Pancreatic Well-differentiated NETs [Recruiting]

Fludarabine Plus Octreotide in Treating Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma [Completed]

Role of Octreotide in Preventing Pancreatic Fistula After Pancreaticoduodenectomy (PD) in Patients With Soft Pancreas [Completed]

Phase II Study of Everolimus Combined With Octreotide LAR to Treat Advanced GI NET [Active, not recruiting]

Sandostatin LAR Depot vs. Surgery for Treating Acromegaly [Completed]

Safety Study of Octreotide Injection to Prevent GI Bleeding in Patients With Left Ventricular Assist Device (LVAD) [Completed]

A Multicenter Placebo-Controlled Double Blind Study to Evaluate the Efficacy and Safety of Sandostatin ( SMS 201-995 ) in Patients With Acquired Immunodeficiency Related Diarrhea Who Were Either "Responders" or "Non-Responders" in a Prior Placebo-Controlled Double-Blind Sandostatin Study. [Completed]

A Multicenter Placebo-Controlled Dose Titration Study to Evaluate the Efficacy and Safety of Sandostatin (SMS 201-995) in the Treatment of Patients With Acquired Immunodeficiency Related Diarrhea [Completed]

Study to Investigate the Antiproliferative Effect of Octreotide in Patients With Metastasized Neuroendocrine Tumors of the Midgut [Active, not recruiting]

Treatment With Octreotide in Patients With Lymphangioleiomyomatosis [Completed]

Octreotide for the Treatment of Sulfonylurea-Associated Hypoglycemia [Completed]

Octreotide in Treating Patients With Locally Advanced or Metastatic Liver Cancer [Completed]

Acute Application of Pegvisomant and Octreotide in Acromegaly [Completed]

A Study To Compare The Efficacy And Safety Of Pegvisomant To That Of Sandostatin Lar Depot In Patients With Acromegaly [Completed]

Treatment of Idiopathic Pulmonary Fibrosis With Long Acting Octreotide [Completed]

Open Label Study of Octreotide Implant in Patients With Acromegaly [Completed]

Food Intake and Gut Hormones in Patients Who Have Undergone Upper Gastrointestinal Surgery for Cancer [Enrolling by invitation]

Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly [Active, not recruiting]

Comparison of Lanreotide Autogel« and Sandostatin LAR Depot in the Treatment of Clinical Symptoms Associated With Carcinoid Syndrome [Terminated]

Surgical Debulking of Pituitary Adenomas [Completed]

Pharmacodynamics Of Product Octreotide Acetate Lar 30 Mg, Imported And Distributed By The Laboratory Chemical Pharmaceutical Bergamo Ltda., Compared To Product Sandostatin LAR « (Octreotide Acetate LAR) 30 MG Manufactured By Novartis Biosciences S / A. [Suspended]

Evaluation of the Efficacy of Long-acting Release Octreotide in Patients With Advanced Hepatocellular Carcinoma [Completed]

Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal Syndrome [Terminated]

Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis [Completed]

Phase 1, Open-label, Drug-drug Interaction Study With Octreotide Acetate Injection and Telotristat Etiprate in Healthy Subjects [Active, not recruiting]

Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy [Completed]

Comparison of Terlipressin, Somatostatin, and Octreotide for Control of Variceal Bleeding [Recruiting]

Octreotide in Treating Patients With Cancer-Related Malignant Ascites [Completed]

Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer [Completed]

Pharmacokinetics, Efficacy and Safety of an Octreotide Implant in Patients With Carcinoid Syndrome [Terminated]

Prediction of Tumor Shrinkage in Acromegaly [Completed]

Effects of Glucagon Administration on Energy Expenditure [Recruiting]

Efficacy of Octreotide Treatment in Patients With Primary Inoperable Thymoma [Completed]

Hector-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma [Completed]

Octreotide VS Placebo in Prevention of Salivary Fistulae After Post Radiation Salvage Surgery [Not yet recruiting]

Randomized Evaluation of Octreotide Versus Compazine for Emergency Department Treatment of Migraine Headache [Recruiting]

Efficacy and Safety of C2L-OCT-01 PR in Acromegalic Patients [Completed]

Safety and Efficacy of Octreotide Long Acting Release (LAR) in Treatment Naïve Acromegalic Patients [Completed]

A Study of IMC-A12 in Islet Cell Cancer [Active, not recruiting]

Effect of Octreotide on the Colonic Motility in Pediatric Patients [Completed]

The Effect of Satiety Gut Hormone Modulation on Appetitive Drive After Upper Gastrointestinal Surgery [Enrolling by invitation]

Effects of Octreotide Acetate on Circulating Levels of Chromogranin A in Advanced Prostate Cancer Patients [Completed]

STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced Diarrhea [Completed]

Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly [Completed]

The Use of Drugs to Improve Kidney Function in Patients With Liver and Kidney Dysfunction [Completed]

Safety and Efficacy of Long-acting Repeatable Octreotide Acetate for Injectable Suspension vs. Surgery in Treatment-naïve Patients With Acromegaly [Completed]

Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy [Completed]

Octreotide and Doxorubicin in Treating Patients With Advanced Cancer [Completed]

Study to Assess the Efficacy and Safety of Monthly Octreotide Intramuscular Injections in Patients With Proliferative Diabetic Retinopathy After Lasercoagulation This Study is Not Being Conducted in the United States. [Terminated]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017